Global Heart Pump Device Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Heart Pump Device Market is presumed to reach the market size of nearly USD 20.36 Billion by 2032 from USD 3.92 Billion in 2023 with a CAGR of 20.09% under the study period 2024 - 2032.

A heart pump device, also known as a ventricular assist device (VAD) or mechanical circulatory support device, is used to replace or support the function of a failing heart. It is typically implanted surgically and assists the heart in pumping blood throughout the body, alleviating symptoms of heart failure and improving circulation. It can be used as a bridge to heart transplantation, as a destination therapy for individuals ineligible for transplant, or as a temporary support measure during recovery from cardiac surgery.

MARKET DYNAMICS

The increasing prevalence of cardiovascular conditions, such as coronary artery disease, heart failure, and cardiomyopathy, coupled with an aging population and lifestyle factors, is driving the demand for heart pump devices as life-saving treatment options for patients with severe heart failure. Additionally, advancements in medical device technology, including miniaturization, wireless connectivity, and sensor integration, enable the development of next-generation heart pump devices with improved reliability, durability, and patient outcomes. Furthermore, the growing acceptance of mechanical circulatory support devices, such as total artificial hearts (TAHs) and ventricular assist devices (VADs), as standard-of-care treatments for end-stage heart failure patients is driving market expansion.

Moreover, the expanding indications for heart pump devices, including destination therapy, bridge-to-transplantation, and bridge-to-recovery, are widening the patient population eligible for device implantation and stimulating market growth. Additionally, the increasing adoption of minimally invasive surgical techniques and percutaneous implantation procedures is expanding access to treatment and driving market penetration. Furthermore, strategic collaborations and partnerships between medical device manufacturers, healthcare providers, and research institutions foster innovation and accelerate the development and commercialization of advanced heart pump technologies. However, limitations in reimbursement policies and competition from alternative treatments may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of heart pump device. The growth and trends of heart pump device industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the heart pump device market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Implanted Heart Pump Devices
Extracorporeal Heart Pump Devices

By Product

Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD), Bi-Ventricular Assist Devices (Bivad), Percutaneous Ventricular Assist Devices (PVAD))
Total Artificial Hearts (TAHs)
Intra-Aortic Balloon Pumps (IABPs)
Extracorporeal Membrane Oxygenation (ECMO)

By End-Use

Hospitals
Cardiac Centers
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Heart Pump Device market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Heart Pump Device market include Abbott, Abiomed, CorWave SA, LivaNova PLC, Berlin Heart, SynCardia Systems, LLC, Jarvik Heart, BiVACOR Inc., Leviticus Cardio, Evaheart, Inc., Teleflex Incorporated, Getinge AB., Carmat, Fresenius SE & Co. KgaA. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112114272

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. HEART PUMP DEVICE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Product
- 3.7.3 Market Attractiveness Analysis By End-Use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL HEART PUMP DEVICE MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data
5.3. Analysis By Type
5.4. Implanted Heart Pump Devices Historic and Forecast Sales By Regions
5.5. Extracorporeal Heart Pump Devices Historic and Forecast Sales By Regions

6. GLOBAL HEART PUMP DEVICE MARKET ANALYSIS BY PRODUCT

6.1. Overview By Product
6.2. Historical and Forecast Data
6.3. Analysis By Product
6.4. Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD), Bi-Ventricular Assist Devices (BiVAD), Percutaneous Ventricular Assist Devices (PVAD)) Historic and Forecast Sales By Regions
6.5. Total Artificial Hearts (TAHs) Historic and Forecast Sales By Regions
6.6. Intra-Aortic Balloon Pumps (IABPs) Historic and Forecast Sales By Regions
6.7. Extracorporeal Membrane Oxygenation (ECMO) Historic and Forecast Sales By Regions

7. GLOBAL HEART PUMP DEVICE MARKET ANALYSIS BY END-USE

7.1. Overview By End-Use
7.2. Historical and Forecast Data
7.3. Analysis By End-Use
7.4. Hospitals Historic and Forecast Sales By Regions
7.5. Cardiac Centers Historic and Forecast Sales By Regions
7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL HEART PUMP DEVICE MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE HEART PUMP DEVICE COMPANIES

9.1. Heart Pump Device Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF HEART PUMP DEVICE INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Abbott
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Abiomed
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. CorWave SA
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. LivaNova PLC
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Berlin Heart
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. SynCardia Systems LLC
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Jarvik Heart
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. BiVACOR Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Leviticus Cardio
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Evaheart Inc.
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Teleflex Incorporated
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. Getinge AB.
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments
10.15. Carmat
- 10.15.1 Company Overview
- 10.15.2 Company Revenue
- 10.15.3 Products
- 10.15.4 Recent Developments
10.16. Fresenius SE & Co. KgaA
- 10.16.1 Company Overview
- 10.16.2 Company Revenue
- 10.16.3 Products
- 10.16.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies